CS
ICPT

Candriam SCA’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Candriam SCA’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-80,000
Closed -$8.95M – 845
2019
Q1 		$8.95M Buy
+80,000
New +$8.74M 0.11% 212
2018
Q1 		– Sell
-32,000
Closed -$1.87M – 796
2017
Q4 		$1.87M Buy
32,000
+17,000
+113% +$1.07M 0.03% 469
2017
Q3 		$871K Sell
15,000
-9,500
-39% -$1.02M 0.02% 591
2017
Q2 		$2.97M Buy
24,500
+3,000
+14% +$348K 0.06% 385
2017
Q1 		$2.43M Hold
21,500
– – 0.05% 404
2016
Q4 		$2.34M Hold
21,500
– – 0.05% 343
2016
Q3 		$3.54M Sell
21,500
-1,500
-7% -$236K 0.09% 253
2016
Q2 		$3.28M Sell
23,000
-15,000
-39% -$2.19M 0.09% 241
2016
Q1 		$4.86M Buy
38,000
+4,200
+12% +$496K 0.12% 199
2015
Q4 		$5.05M Sell
33,800
-6,000
-15% -$1.02M 0.14% 177
2015
Q3 		$6.6M Sell
39,800
-16,200
-29% -$3.56M 0.16% 162
2015
Q2 		$13.5M Buy
56,000
+7,000
+14% +$1.86M 0.28% 98
2015
Q1 		$13.8M Buy
49,000
+14,000
+40% +$3.03M 0.28% 93
2014
Q4 		$5.46M Buy
+35,000
New +$6.46M 0.11% 217

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Candriam SCA's ICPT Position: Q2 2019 in Review

Candriam SCA sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2019, closing a stake of 80,000 shares — an estimated $8.95M sold.

Candriam SCA first reported a position in ICPT in Q4 2014 and held it in 14 quarters. The position peaked at $13.8M in Q1 2015. 196 funds tracked by Wall St. Rank hold ICPT as of Q2 2019.

  • Candriam SCA reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Candriam SCA sold 80,000 Intercept Pharmaceuticals, Inc. shares in Q2 2019, an estimated $8.95M.
  • Candriam SCA first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2014 and held it in 14 quarters.
  • Candriam SCA's Intercept Pharmaceuticals, Inc. position peaked at $13.8M in Q1 2015.
  • 196 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2019.

Based on Candriam SCA's 13F filing for Q2 2019, filed 1 Aug 2019.